{
  "N/R/U": null,
  "Applicant": "GlaxoSmithKline Biologicals",
  "BLA Number": "125265",
  "Proprietary Name": "Rotarix",
  "Proper Name": "Rotavirus Vaccine, Live, Oral",
  "BLA Type": "351(a)",
  "Strength": "106.0CCID50",
  "Dosage Form": "Suspension",
  "Route of Administration": "Oral",
  "Product Presentation": "Tube",
  "Marketing Status": "Disc",
  "Licensure": "Licensed",
  "Approval Date": "4-Nov-22",
  "Ref. Product Proper Name": " ",
  "Ref. Product Proprietary Name": " ",
  "Supplement Number": "645",
  "Submission Type": "Supplement",
  "License Number": "1617",
  "Product Number": "2",
  "Center": "CBER",
  "Date of First Licensure": null,
  "Exclusivity Expiration Date": null,
  "First Interchangeable Exclusivity Exp. Date": null,
  "Ref. Product Exclusivity Exp. Date": null,
  "Orphan Exclusivity Exp. Date": null
}